SML3597
ARUK3001185
≥98% (HPLC)
别名:
1-[2,4-Dichloro-3-(trifluoromethyl)phenyl]-1H-1,2,3-triazole
InChI
1S/C9H4Cl2F3N3/c10-5-1-2-6(17-4-3-15-16-17)8(11)7(5)9(12,13)14/h1-4H
InChI key
XVFXHCLMGYJAQI-UHFFFAOYSA-N
SMILES string
ClC1=C(C(Cl)=CC=C1N2C=CN=N2)C(F)(F)F
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Quality Level
Biochem/physiol Actions
ARUK3001185 is a brain-penetrant, orally available, potent and selective carboxylesterase Notum inhibitor (IC50 = 6.7 nM) and Wnt signaling activator with no cross-reactivity toward panels of 39 serine hydrolases, 485 kinases (IC50 >10 μM), and 47 human off-target liabilities (IC50 >30 μM).
Brain-penetrant, orally available, potent and selective carboxylesterase Notum inhibitor and Wnt signaling activator.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling
Journal of Medicinal Chemistry, 64(8), 4289-4311 (2021)
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit
Journal of medicinal chemistry, 65(10), 7212-7230 (2022)
Small-molecule inhibitors of carboxylesterase Notum
Future medicinal chemistry, 13(11), 1001-1015 (2021)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持